LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 86.03 | 21.74 | 442 | 6155 | 0.0718 | 0.4475 | MN20160310_N01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 86.03 | 21.74 | 1 | 6155 | 0.0002 | -0.3148 | MN20160310_N01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 86.03 | 21.74 | 18 | 6155 | 0.0029 | -0.0229 | MN20160310_N01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 88.00 | 21.74 | 1 | 6081 | 0.0002 | -0.3153 | MN20160310_N01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 88.00 | 21.74 | 446 | 6081 | 0.0733 | 0.4502 | MN20160310_N01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 88.00 | 21.74 | 1 | 6081 | 0.0002 | -0.3153 | MN20160310_N01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 88.00 | 21.74 | 18 | 6081 | 0.0030 | -0.0230 | MN20160310_N01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 89.97 | 21.74 | 1 | 6084 | 0.0002 | -0.3153 | MN20160310_N01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 89.97 | 21.74 | 433 | 6084 | 0.0712 | 0.4449 | MN20160310_N01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 89.97 | 21.74 | 1 | 6084 | 0.0002 | -0.3153 | MN20160310_N01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 89.97 | 21.74 | 14 | 6084 | 0.0023 | -0.0527 | MN20160310_N01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 91.94 | 21.74 | 1 | 6121 | 0.0002 | -0.3150 | MN20160310_N01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 91.94 | 21.74 | 449 | 6121 | 0.0733 | 0.4508 | MN20160310_N01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 91.94 | 21.74 | 1 | 6121 | 0.0002 | -0.3150 | MN20160310_N01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 91.94 | 21.74 | 13 | 6121 | 0.0021 | -0.0612 | MN20160310_N01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 93.92 | 21.74 | 1 | 6070 | 0.0002 | -0.3154 | MN20160310_N01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 93.92 | 21.74 | 465 | 6070 | 0.0766 | 0.4579 | MN20160310_N01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 93.92 | 21.74 | 1 | 6070 | 0.0002 | -0.3154 | MN20160310_N01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 93.92 | 21.74 | 15 | 6070 | 0.0025 | -0.0446 | MN20160310_N01 | L09 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.0010833 | 2.24 | 21.74 | 6 | 183 | 0.0327 | -0.3418 | MN20160310_N01 | H22 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.0010833 | 2.24 | 21.74 | 545 | 183 | 2.9689 | 1.8482 | MN20160310_N01 | H22 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.0010833 | 2.24 | 21.74 | 11 | 183 | 0.0599 | -0.1986 | MN20160310_N01 | M20 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.0010833 | 2.24 | 21.74 | 672 | 183 | 3.6607 | 2.0488 | MN20160310_N01 | M20 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.0010833 | 4.24 | 21.74 | 5 | 317 | 0.0157 | -0.3160 | MN20160310_N01 | H22 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.0010833 | 4.24 | 21.74 | 727 | 317 | 2.2877 | 1.4769 | MN20160310_N01 | H22 |